Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuedexta for Bulbar Dysfunction in ALS
NCT01806857Phase 2Completed
- Sponsor
- Center for Neurologic Study
- Start
- Apr 2013
- Primary completion
- Mar 2015
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dextromethorphan + quinidine in amyotrophic lateral sclerosis (ALS), sponsored by Center for Neurologic Study. Started Apr 2013; status: completed.
02
Drugs
dextromethorphan + quinidine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT01806857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01806857.